We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Pharmaceutical Care in Depressed Outpatients (depression)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Ana Regina Noto, Federal University of São Paulo.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01571973
First Posted: April 5, 2012
Last Update Posted: April 5, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Ana Regina Noto, Federal University of São Paulo
April 3, 2012
April 5, 2012
April 5, 2012
March 2010
March 2012   (Final data collection date for primary outcome measure)
depression level [ Time Frame: six months ]
evaluation depression level by Beck scale
Same as current
No Changes Posted
  • anxiety level [ Time Frame: 6 months ]
    evaluation anxiety level by Beck scale.
  • compliance [ Time Frame: 6 months ]
    evaluation antidepressive treatment compliance by Morisky scale
Same as current
Not Provided
Not Provided
 
Evaluation of Pharmaceutical Care in Depressed Outpatients
EVALUATION OF THE EFFECTIVENESS OF PHARMACEUTICAL CARE (DÁDER PROGRAM) IN DEPRESSED OUTPATIENTS TREATED WITH PSYCHOTROPIC
The study examines whether pharmacotherapeutic follow-up improves outcomes of treatment of depressed outpatients.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Depression
Procedure: pharmacotherapeutic follow-up
health education adjustment of dose improve compliance replacement of medication
  • No Intervention: control group
    outpatients receiving usual care
  • Experimental: intervention group
    outpatients receiving pharmaceutical care or pharmacotherapeutic follow-up by 6 months
    Intervention: Procedure: pharmacotherapeutic follow-up
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
60
May 2012
March 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • women between 18 and 65 years, with diagnostic hypothesis of depression at the beginning of treatment or change in treatment unless 2 months (dosage or substance)

Exclusion Criteria:

  • record of dependence on psychoactive substances, diagnosed schizophrenia,
  • low education (illiterate) or cognitive impairment evident that compromise the completion of research instruments
Sexes Eligible for Study: Female
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01571973
SPPsicobio1Lu
Yes
Not Provided
Not Provided
Ana Regina Noto, Federal University of São Paulo
Federal University of São Paulo
Not Provided
Not Provided
Federal University of São Paulo
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP